A blanket ban of so-called ‘legal highs’ is due to come into effect this spring, following long-running concerns over how quickly they are being created and the potential harms they pose (Office of National Statistics)
Archives for April 2016
Bibliography: All Publications
ACMD work programme for 2016
Letter to the Home Secretary from the chair of the Advisory Council on the Misuse of Drugs, outlining their work programme for 2016 (AMCD)
Crime in England and Wales: Year ending December 2015
Includes: Drug offences, Trafficking of drugs, Possession of drugs (ONS)
Marijuana Legalization in Colorado: Early Findings
A Report Pursuant to Senate Bill 13-283 (Colorado Department of Public Safety, Division of Criminal Justice)
Service Review: Take Home Naloxone programme in NI
Consultation with service users and service providers (Public Health Agency)
Precursor chemical licensing
Licence and registration application information for companies that deal in precursor chemicals (Home Office)
Bringing State Commitments to Gender Equality into Action
This document, published by INWUD and INPUD focusses on the needs of women who use drugs, and calls for drug policy to align with the 2030 Agenda for Sustainable Development, and in doing so, uphold our right to health and human rights, development and gender equalit
Public Health England Strategic Plan
Includes alcohol and drug use (Public Health England)
Do no harm – Health, human rights and people who use drugs
Evidence supports the need for a shift in the global approach to drug use. In this report, Do no harm: health, human rights and people who use drugs, UNAIDS shows what works to reduce the impact of HIV and other harms related to drug use (UNAIDS)
The Challenge of Being Young in Modern Britain
Includes substance abuse (YMCA)
Controlled drugs: safe use and management
Providers of services where controlled drugs are used, for example, substance misuse services, ambulance services, home care providers, community pharmacies, community health providers, GPs and other independent prescribers, dispensing doctors, voluntary agencies and charities (NICE)
Through a Broken Glass, Darkly; Drug Policy and the War in Afghanistan
Policy Report 5 – March 2016 (Global Drug Policy Observatory)
Research Report: The New Zealand Drug Harm Index 2016
The New Zealand Drug Harm Index 2016 estimates the social cost of drug-related harms and intervention costs in 2014/15 as NZ$1.8 billion (Ministry of Health, New Zealand)
An evaluation of the CAD Family Focused Drug Education Programme and Tutor Training Programme
This report presents the results of a pilot training evaluation in the North East region to assess (1) the training and delivery of the CAD Family Focus Tutor Training programme and (2) the impact of the CAD Family Focus Drug Education programme on participants (North East Regional Drug & Alcohol Task Force)
National Drugs Strategy 2009-2016
Progress Report to End 2015 (Drugs.ie)
Model-based appraisal of the comparative impact of Minimum Unit Pricing and taxation policies in Scotland
An adaptation of the Sheffield Alcohol Policy Model version 3 (University of Sheffield)
Effect of policy, economics, and the changing alcohol marketplace on alcohol related deaths in England and Wales
The economic downturn and rises in alcohol taxation seem to have stemmed the persistent rise in alcohol related deaths in England and Wales (BMJ)
EU Drug Markets Report
The 2016 EU Drug Markets Report provides a unique insight into the operation of illicit drug markets in the EU. The report assesses the impact of the drug market on society and the factors driving it. It explores the market for cannabis, heroin, cocaine, amphetamines, MDMA and new psychoactive substances (EMCDDA)
Trends in drug misuse deaths in England, 1999 to 2014
This report presents year-by-year data on drug misuse deaths in England from 1999 to 2014. The Office for National Statistics (ONS) reported a 17% increase in drug misuse deaths registered in England in 2014, following an increase of 21% in 2013 (PHE)
Study on Extended-Release Naltrexone in Opioid-Dependent Patients Involved in Criminal Justice System
Investigator-Led Study Showed Treatment With Extended-Release Naltrexone Reduced Relapse Rates and Demonstrated Longer Median Time to Relapse to Opioid Dependence During Six-Month Treatment Period (Bloomberg)